Exelixis
EXEL
#1676
Rank
HK$100.93 B
Marketcap
HK$401.58
Share price
-2.29%
Change (1 day)
23.69%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company